TIMM13 and sarcoma: The Cancer Genome Atlas (TCGA) database was consulted next and Kaplan–Meier survival results revealed that high TIMM13 expression in sarcoma patients tended to have a poor prognosis (P = 0.09) (Fig. 1C).